A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors | MicrobiomeTrials← Back to trialsNCT03693014
A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2018-10-01Est. Completion: 2027-10
Enrollment target: 69 participants Locations- Hartford Healthcare, Hartford, Connecticut, United States
- Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
- Memorial Sloan Kettering Commack, Commack, New York, United States
- Memorial Sloan Kettering Westchester, Harrison, New York, United States
- Memorial Sloan Kettering Cancer Center, New York, New York, United States
- Memorial Sloan Kettering Rockville Centre, Rockville Centre, New York, United States
- Memorial Sloan Kettering Nassau, Uniondale, New York, United States
- Lehigh Valley Health Network, Allentown, Pennsylvania, United States
Other microbiome trials you might be interested in
Hepatocellular Carcinoma
A single institution, single arm, two-cohort feasibility trial to evaluate the combination of locoregional Y\^90 therapy…
New York, United StatesEst. completion Aug 1, 2027
Colorectal NeoplasmsNeoplasmsIntrahepatic CholangiocarcinomaAdrenocortical CarcinomaMetastasis, Neoplasm
Background:
Cancers that begin in the colon, adrenal glands, or bile ducts may spread to the liver. These liver tumors …
Bethesda, United States
Est. completion Dec 31, 2029
Metastatic Uveal Melanoma
Because we suspect that the benefit of anti-PD-1 in metastatic UM patients could vary according to previous exposure to …
Paris, FranceCompleted Apr 28, 2025